These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 16799362

  • 1. The effects of managed care and competition on community-based clinical research.
    Carpenter WR, Weiner BJ, Kaluzny AD, Domino ME, Lee SY.
    Med Care; 2006 Jul; 44(7):671-9. PubMed ID: 16799362
    [Abstract] [Full Text] [Related]

  • 2. Performance in quasi-firms: an example from the Community Clinical Oncology Program.
    Lacey LM, Hynes DM, Kaluzny AD.
    J Health Hum Resour Adm; 1992 Jul; 14(3):307-26. PubMed ID: 10118501
    [Abstract] [Full Text] [Related]

  • 3. Predicting the performance of a strategic alliance: an analysis of the Community Clinical Oncology Program.
    Kaluzny AD, Lacey LM, Warnecke R, Hynes DM, Morrissey J, Ford L, Sondik E.
    Health Serv Res; 1993 Jun; 28(2):159-82. PubMed ID: 8514498
    [Abstract] [Full Text] [Related]

  • 4. Adapting clinical trials networks to promote cancer prevention and control research.
    Weiner BJ, McKinney MM, Carpenter WR.
    Cancer; 2006 Jan 01; 106(1):180-7. PubMed ID: 16333855
    [Abstract] [Full Text] [Related]

  • 5. Community Clinical Oncology Program participation in the Breast Cancer Prevention Trial: factors affecting accrual.
    Klabunde C, Kaluzny A, Ford L.
    Cancer Epidemiol Biomarkers Prev; 1995 Jan 01; 4(7):783-9. PubMed ID: 8672997
    [Abstract] [Full Text] [Related]

  • 6. Ecological analysis of the first generation of community clinical oncology programs.
    Schopler JH.
    Health Serv Res; 1993 Apr 01; 28(1):69-95. PubMed ID: 8463110
    [Abstract] [Full Text] [Related]

  • 7. Using a community cancer treatment trials network for cancer prevention and control research: challenges and opportunities.
    Kaluzny AD, Lacey LM, Warnecke R, Morrissey JP, Sondik E, Ford L.
    Cancer Epidemiol Biomarkers Prev; 1994 Apr 01; 3(3):261-9. PubMed ID: 8019377
    [Abstract] [Full Text] [Related]

  • 8. Competition in hospital and health insurance markets: a review and research agenda.
    Morrisey MA.
    Health Serv Res; 2001 Apr 01; 36(1 Pt 2):191-221. PubMed ID: 11327174
    [Abstract] [Full Text] [Related]

  • 9. Accrual to National Cancer Institute-sponsored non-small-cell lung cancer trials: insights and contributions from the CCOP program.
    Lyss AP, Lilenbaum RC.
    Clin Lung Cancer; 2009 Nov 01; 10(6):410-3. PubMed ID: 19900858
    [Abstract] [Full Text] [Related]

  • 10. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
    Buchanan DR, White JD, O'Mara AM, Kelaghan JW, Smith WB, Minasian LM.
    J Clin Oncol; 2005 Sep 20; 23(27):6682-9. PubMed ID: 16170176
    [Abstract] [Full Text] [Related]

  • 11. Recruiting participants to cancer prevention clinical trials: lessons from successful community oncology networks.
    McKinney MM, Weiner BJ, Wang V.
    Oncol Nurs Forum; 2006 Sep 01; 33(5):951-9. PubMed ID: 16955123
    [Abstract] [Full Text] [Related]

  • 12. The Outcomes of Cancer Outcomes Research: focusing on the National Cancer Institute's quality-of-care initiative.
    Lipscomb J, Snyder CF.
    Med Care; 2002 Jun 01; 40(6 Suppl):III3-10. PubMed ID: 12064755
    [Abstract] [Full Text] [Related]

  • 13. Delaware/Christiana Care Community Clinical Oncology Program (CCOP): a National Cancer Institute clinical trials program.
    Price K.
    Del Med J; 2007 Jun 01; 79(6):247-51. PubMed ID: 17621871
    [No Abstract] [Full Text] [Related]

  • 14. Medicare HMO penetration and mortality outcomes of ischemic stroke.
    Bian J, Dow WH, Matchar DB.
    Am J Manag Care; 2006 Jan 01; 12(1):58-64. PubMed ID: 16402889
    [Abstract] [Full Text] [Related]

  • 15. A new measure of the impact of managed care on healthcare markets.
    Pawlson LG, Moy EM, Kim JI, Griner PF.
    Am J Manag Care; 2001 Nov 01; 7(11):1069-77. PubMed ID: 11725810
    [Abstract] [Full Text] [Related]

  • 16. Sustainability and performance of the National Cancer Institute's Community Clinical Oncology Program.
    Carpenter WR, Fortune-Greeley AK, Zullig LL, Lee SY, Weiner BJ.
    Contemp Clin Trials; 2012 Jan 01; 33(1):46-54. PubMed ID: 21986391
    [Abstract] [Full Text] [Related]

  • 17. Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience.
    McCaskill-Stevens W, McKinney MM, Whitman CG, Minasian LM.
    J Clin Oncol; 2005 Aug 01; 23(22):5247-54. PubMed ID: 16051967
    [Abstract] [Full Text] [Related]

  • 18. Clinical Trials: A Congressional Focus of Need.
    Coltman CA.
    Oncologist; 1997 Aug 01; 2(4):VII-VIII. PubMed ID: 10388059
    [Abstract] [Full Text] [Related]

  • 19. Clinical trial accrual among new cancer patients at a community-based cancer center.
    Go RS, Frisby KA, Lee JA, Mathiason MA, Meyer CM, Ostern JL, Walther SM, Schroeder JE, Meyer LA, Umberger KE.
    Cancer; 2006 Jan 15; 106(2):426-33. PubMed ID: 16353206
    [Abstract] [Full Text] [Related]

  • 20. HMO growth and the geographical redistribution of generalist and specialist physicians, 1987-1997.
    Escarce JJ, Polsky D, Wozniak GD, Kletke PR.
    Health Serv Res; 2000 Oct 15; 35(4):825-48. PubMed ID: 11055451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.